4.7 Article

Risk-Standardizing Survival for In-Hospital Cardiac Arrest to Facilitate Hospital Comparisons

期刊

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2013.05.051

关键词

cardiac arrest; risk adjustment; variation in care

资金

  1. U.S. National Institutes of Health
  2. National Heart Lung and Blood Institute (NHBLI) [K23HL102224, K23109083]
  3. AHA
  4. Amarin
  5. AstraZeneca
  6. Bristol-Myers Squibb
  7. Eisai
  8. Ethicon
  9. Medtronic
  10. Sanofi Aventis
  11. Medicines Company
  12. FlowCo
  13. PLx Pharma
  14. Takeda
  15. NHLBI
  16. AHRQ
  17. NIH [10714038]
  18. Lilly
  19. Amorcyte
  20. Genentech
  21. Physio-Control
  22. Zoll Medical
  23. Cardiac Science
  24. Philips Medical

向作者/读者索取更多资源

Objectives The purpose of this study is to develop a method for risk-standardizing hospital survival after cardiac arrest. Background A foundation with which hospitals can improve quality is to be able to benchmark their risk-adjusted performance against other hospitals, something that cannot currently be done for survival after in-hospital cardiac arrest. Methods Within the Get With The Guidelines (GWTG)-Resuscitation registry, we identified 48,841 patients admitted between 2007 and 2010 with an in-hospital cardiac arrest. Using hierarchical logistic regression, we derived and validated a model for survival to hospital discharge and calculated risk-standardized survival rates (RSSRs) for 272 hospitals with at least 10 cardiac arrest cases. Results The survival rate was 21.0% and 21.2% for the derivation and validation cohorts, respectively. The model had good discrimination (C-statistic 0.74) and excellent calibration. Eighteen variables were associated with survival to discharge, and a parsimonious model contained 9 variables with minimal change in model discrimination. Before risk adjustment, the median hospital survival rate was 20% (interquartile range: 14% to 26%), with a wide range (0% to 85%). After adjustment, the distribution of RSSRs was substantially narrower: median of 21% (interquartile range: 19% to 23%; range 11% to 35%). More than half (143 [52.6%]) of hospitals had at least a 10% positive or negative absolute change in percentile rank after risk standardization, and 50 (23.2%) had a >= 20% absolute change in percentile rank. Conclusions We have derived and validated a model to risk-standardize hospital rates of survival for in-hospital cardiac arrest. Use of this model can support efforts to compare hospitals in resuscitation outcomes as a foundation for quality assessment and improvement. (C) 2013 by the American College of Cardiology Foundation

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据